The efficacy was tested using the duality of histone modifications at MLH1 gene promoter in human colorectal cancer (CRC) cell lines RKO (silenced, H3k27me3 enriched) versus SW480 (expressed, H3K4me3 enriched), as established from previous work [18]. Here, MLH1 is linked to colorectal carcinoma.